About the Authors
- Véronique Calleja
-
Contributed equally to this work with: Véronique Calleja, Michel Laguerre
*To whom correspondence should be addressed. E-mail: banafshe.larijani@cancer.org.uk (BL); Veronique.calleja@cancer.org.uk (VC)
Affiliation Cell Biophysics Laboratory, Cancer Research UK, Lincoln's Inn Fields Laboratories, London Research Institute, London, United Kingdom
- Michel Laguerre
-
Contributed equally to this work with: Véronique Calleja, Michel Laguerre
Affiliation UMR 5248-CNRS, Institut Européen de Chimie et Biologie, Pessac, France
- Peter J Parker
-
Affiliations Protein Phosphorylation Laboratory, Cancer Research UK, Lincoln's Inn Fields Laboratories, London Research Institute, London, United Kingdom , Division of Cancer Studies KCL, Guy's Hospital, London, United Kingdom
- Banafshé Larijani
-
*To whom correspondence should be addressed. E-mail: banafshe.larijani@cancer.org.uk (BL); Veronique.calleja@cancer.org.uk (VC)
Affiliation Cell Biophysics Laboratory, Cancer Research UK, Lincoln's Inn Fields Laboratories, London Research Institute, London, United Kingdom
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
VC and BL were involved in the design of the FRET experiments. VC performed the FRET experiments. VC was responsible for the design of the molecular biology tools and performed the biochemical experiments. ML was responsible for the molecular modelling. VC and BL were responsible for the set up and optimisation of two-photon FLIM. VC, ML, PJP, and BL were involved in the project strategy and in the scientific discussions. BL supervised the project. VC, ML, PJP, and BL were involved in writing the manuscript.